Blood clot risk elevated with contraceptive patches, vaginal rings Women who use the combined contraceptive transdermal patch or vaginal ring are at significantly higher risk for venous thrombosis, ...

The new labeling for the patch will include information about the higher levels of estrogen.The Ortho Evra contraceptive patch, produced by Ortho McNeil Pharmaceuticals, a unit of Johnson & Johnson ...

This could be a tough pill to swallow. Scientists in Denmark examined the heart attack and stroke risks associated with vaginal rings, skin patches, IUDs, implants inserted under the skin, injections, ...

EE: Ethinyl estradiol; LNG: Levonorgestrel; OC: Oral contraceptive; RR: Relative risk; VTE: Venous thromboembolism. Transdermal contraceptive patches provide a more convenient delivery system for ...

WASHINGTON, Jan 18 (Reuters) - The label for a Johnson & Johnson contraceptive patch will include new data from a second study showing a higher risk of blood clots compared with birth-control pills, U ...

WASHINGTON -- Federal health officials approved sale of the world's first contraceptive patch yesterday, giving women an option considered as safe and effective as the pill but easier for some to use.

The patch supplies norelgestromin and ethinyl estradiol to the bloodstream through the skin. Has any evidence of genital swelling been documented with the use of the patch when placed inappropriately?